Tag: DBS
Abbott launches Liberta RC deep brain stimulation system with remote programming...
Abbott recently announced that it has received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC deep brain stimulation...
Researchers detail “more elegant” DBS approach for improving Parkinson’s symptoms
A team of physicians, neuroscientists and engineers at Duke University (Durham, USA) have reported multiple new strategies that use deep brain stimulation (DBS) to...
Medtronic gains US FDA approval for Percept RC deep brain stimulation...
Medtronic has announced the US Food and Drug Administration (FDA) approval of its Percept RC deep brain stimulation (DBS) system.
The rechargeable neurostimulator is the...
Boston Scientific to present late-breaking data at NANS 2024
Boston Scientific Corporation has announced its clinical data that will be featured at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January,...
Evolving the standard of care: What is next for functional neurosurgery?
The proliferation of new technologies and advancements in the neurosciences space has showed little sign of slowing in recent years and—as John Rolston (Boston,...
Surgical Information Sciences initiates VISION study to support DBS for Parkinson’s...
Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus...
Researchers develop non-surgical DBS technology capable of boosting memory accuracy
Researchers at the UK Dementia Research Institute (DRI) have developed a new form of deep brain stimulation (DBS) that does not require surgery and...
Enspire announces publication of trial evaluating DBS plus rehab for stroke...
Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing...
New spectroscopy probe could enhance deep brain stimulation procedures for Parkinson’s
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors...
Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...
New CMS telehealth designation extends coverage of Abbott’s NeuroSphere virtual clinic
As part of its Medicare Telehealth Services List, the US Centers for Medicare and Medicaid Services (CMS) will continue to cover the use of...
Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system
Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...
Abbott receives Breakthrough Device designation to explore DBS in managing severe...
Abbott recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to investigate the use of its deep brain...
INS 2022: Late-breaking research indicates safety of deep brain stimulation in...
Deep brain stimulation (DBS) offers a safe therapy option for reducing chorea in patients with Huntington’s disease, but it remains to be seen whether...
NeuroOne releases successful completion of long-term stimulation tests with novel, thin-film...
NeuroOne Medical Technologies has announced that it successfully completed initial, bench-top, long-term stimulation testing on a novel design of its thin-film electrode technology. The...
Single-patient study offers promise for individualised depression treatment with DBS
Despite its small sample size, a study in which a patient received closed-loop, deep brain stimulation (DBS) therapy has demonstrated positive clinical outcomes and...
Researchers pave way for adaptive DBS treatment after identifying OCD-associated brain...
In an effort to improve treatment for obsessive-compulsive disorder (OCD), a team of researchers has—for the first time, according to a Brown University (Providence,...
Patient assent and lack of evidence among key ethical concerns identified...
A study intended to gain insight into prevailing ethical issues surrounding the use of deep brain stimulation (DBS) in adolescents with obsessive-compulsive disorder (OCD)...
Research shows brain rhythm changes occur ‘within minutes’ of DBS surgery...
New research published in Translational Psychiatry presents evidence that brief intraoperative exposure to therapeutic deep brain stimulation (DBS) at the time of implantation surgery induces...
Rune Labs and Medtronic partner to improve understanding of neurostimulation with...
Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and global healthcare...
Allegheny Health Network initiates clinical trial exploring use of DBS to...
A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US Food and Drug Administration (FDA) approval to begin the...
Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...
How stimulation is changing the future of mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...
New algorithm could enable next-generation deep brain stimulation devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...
Medtronic receives CE mark for SenSight directional lead system for DBS...
Medtronic has announced that it has received CE mark for the SenSight directional lead system for deep brain stimulation (DBS) therapy as treatment of...
Newronika announces CE mark for AlphaDBS system
Newronika has announced the CE mark approval for its AlphaDBS system to treat Parkinson’s disease. According to a company press release, Newronika is a spin-off of the world-class neurological research centre Policlinico of Milan...
Vercise Genus DBS system received FDA approval
Boston Scientific has announced that it has received US Food and Drug Administration (FDA) approval for its fourth-generation Vercise Genus deep brain stimulation (DBS) system.
According to a company press release, the...
New study reports directional DBS provides superior results to omnidirectional DBS...
Results from a multi-centre, prospective, blinded, crossover study, presented at the North American Neuromodulation Society (NANS) virtual meeting (15–16 January) by Jan Vesper (Heinrich-Heine...
Medtronic launches aDBS trial in Parkinson’s disease patients
Medtronic has announced the first enrolment in its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson’s...
Vercise DBS receives breakthrough device designation from FDA
Functional Neuromodulation has announced that the Vercise deep brain stimulation (DBS) device, developed and manufactured by Boston Scientific, has received breakthrough device designation from...
Asleep surgery improves the therapeutic window for deep brain stimulation
Evidence in support of the motion that asleep surgery improves the therapeutic window for deep brain stimulation (DBS) when compared to awake surgery, has...
FDA approves Percept PC neurostimulator with BrainSense technology
Medtronic has announced it received US Food and Drug Administration (FDA) approval for the Percept PC deep brain stimulation (DBS) system. BrainSense technology makes...
Abbott receives expanded indication from FDA for directional DBS to treat...
Abbott has announced it received approval from the US Food and Drug Administration (FDA) for a new, expanded indication for the company's Infinity deep...
Aleva Neurotherapeutics receives CE mark for its directSTIM directional Deep Brain...
Aleva Neurotherapeutics has announced that it has been awarded the CE mark for its flagship product, the directSTIM Deep Brain Stimulation System. The system...
Abbott partners with NIH on BRAIN initiative to advance research for...
Abbott have announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative...
Medtronic’s deep brain stimulation for medically-refractory epilepsy launches in the USA
Medtronic has announced both the US launch of deep brain stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University...
Abbott expands its directional deep brain stimulation therapy by offering new...
Parkinson's disease and essential tremor patients can now benefit from upgraded functionality with Abbott's Infinity DBS system. Abbott has announced US Food and Drug...
DBS treatment may slow the progression of parkinson’s tremor in early-stage...
A study at Vanderbilt University Medical Centre, Nashville, USA has provided the first evidence of a treatment that slows the progression of one of...
Deep brain stimulation associated with a decreased risk of fall in...
Chronic subthalamic deep brain stimulation (DBS) is associated with a decreased risk for recurrent falls and delays the onset of psychosis in patients with...
Deep brain stimulation showing promise for patients with mild Alzheimer’s disease...
An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most...
New clinician programmer for deep brain stimulation therapy
The US Food and Drug Administration (FDA) has recently approved Medtronic’s state-of-the art Deep Brain Stimulation (DBS) Clinician Programmer and Activa Programming Application, which...
Positive late-breaking data from the INTREPID study announced
The one-year data from the INTREPID study, the first and only prospective, double-blind, randomised, sham-controlled, multi-centre study of deep brain stimulation (DBS) for advanced,...
Deep brain stimulation shows promise as treatment for Alzheimer’s disease
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and...
